Inventor · disambiguated record
Martin K. Childers
Also filed as: CHILDERS MARTIN K
7 granted patents·2 pending applications·19 citations·filing 2014–2021
82Inventor score
Files withUNIV WAKE FOREST HEALTH SCIENCES6ASKLEPIOS BIOPHARMACEUTICAL INC1GENETHON1UNIV WASHINGTON1
Top patents by PatentIndex Score
9 records- 0191US9415120B2Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2015·Granted Aug 16, 2016·5 cites·31 claims
- 0289US8957044B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2014·Granted Feb 17, 2015·6 cites·15 claims
- 0388US9895426B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Feb 20, 2018·3 cites·56 claims
- 0488US9839677B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Dec 12, 2017·3 cites·10 claims
- 0586US11564977B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2017·Granted Jan 31, 2023·2 cites·36 claims
- 0672US12178856B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 0753US2023374542A1Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)ASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 0837US11661583B2Drug discovery platform for Duchenne cardiomyopathyUNIV WASHINGTON·Filed 2016·Granted May 30, 2023·0 cites·11 claims
- 0932US2017071972A1Method of treating peripheral neuropathies and motor neuron diseasesGENETHON·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin K. Childers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →